The table below shows IOVANCE BIOTHERAPEUTICS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$263.50M
$164.07M
$1.19M
-
-
-
Cost of revenue
$173.18M
$93.25M
$1.03M
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$300.27M
$276.23M
$333.19M
$294.78M
$259.04M
$201.73M
SG&A
IOVA annual revenue (10-K history)
IOVANCE BIOTHERAPEUTICS, INC. reported annual revenue of $263.50M for fiscal year 2025. That is up 60.6% from $164.07M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
